Article
Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutant.
Bioorganic & medicinal chemistry - 15 Dec 2017
Fukuda Tsutomu, Umeki Teppei, Tokushima Keiji, Xiang Gao, Yoshida Yuki, Ishibashi Fumito, Oku Yusuke, Nishiya Naoyuki, Uehara Yoshimasa, Iwao Masatomo
Abstract excerpt
A series of A-ring-modified lamellarin N analogues were designed, synthesized, and evaluated as potential noncovalent inhibitors of the EGFR T790M/L858R mutant, a causal factor in the drug-resistant non-small cell lung cancer. Several water-soluble ammonium- or guanidinium-tethered analogues exhibited good kinase inhibitory activities. The most promising analogue, 14f, displayed an excellent inhibitory profile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
